Natalya Shimokhina

Dr. Natalya Shimokhina

Voino-Yasenetskiy Krasnoyarsk State Medical University
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NSNatalya Shimokhina
Natalya Shimokhina
ASAndrei Savchenko
Andrei Savchenko
MPMarina Petrova
Marina Petrova
Anxiety–depressive disorders (ADD) are a risk factor of cardiovascular mortality in patients with coronary artery disease (CAD). Acute coronary syndrome (ACS) is the main clinical manifestation of a progressing CAD. Metabolic processes disorder in platelets can be one of the causes of cardiovascular complications in patients with ACS and concomitant ADD. We studied platelets metabolism and prognostic informativity of NAD(P)-dependent dehydrogenases of platelets in ACS patients with ADD in terms of forecasting cardiovascular complications development over a year of observation. The levels of NAD- and NADP-dependent dehydrogenases of platelets were determined by means of a bioluminescent method during the first 24 h after admission to hospital and in dynamics in 10 days. Among 315 examined patients, ADD was found in 161 (51.1%). ACS patients with concomitant ADD had both cytoplasmic and mitochondrial processes impairment in platelets that consisted in a decrease of energy metabolism intensity, inhibition of anaerobic glycolysis reactions and lipid catabolism. After 12 months of follow-up, 41 (25.5%) cardiovascular complications were detected in the group of ACS patients with ADD and 20 (13.0%) in the group of ACS patients without ADD. According to the results of the analysis of the neural network based on NAD(P)-dependent dehydrogenases of platelets activity in ACS patients with ADD, indicators were obtained that are informative for predicting the development of recurrent cardiovascular complications.

27 August 2015 in Kardiologiia
Verified
Journal Article
Closed access
NSNatalya Shimokhina
Natalya Shimokhina
ASAndrei Savchenko
Andrei Savchenko
MPM.M. Petrova Petrova
M.M. Petrova Petrova
M(M.S. Chernyaeva (Pilyugina) Chernyaeva (Pilyugina)
M.S. Chernyaeva (Pilyugina) Chernyaeva (Pilyugina)

10 October 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ORO Rotar
O Rotar
EME Moguchaya
E Moguchaya
MBM Boyarinova
M Boyarinova
OROlesya Rubanenko
Olesya Rubanenko
EGE Gubareva
E Gubareva
ESE Shlyakhto
E Shlyakhto
Aim. To evaluate the features of antihypertensive therapy (AHT), adherence to therapy and achievement of target blood pressure (BP) in patients with hypertension (HTN) in Russian real-world practice after the implementation of 2024 Russian clinical guidelines on hypertension in adults.Material and methods. During May 2025, 7990 patients with HTN from 19 Russian cities and Tiraspol (Pridnestrovian Moldavian Republic) took part in the BP measurement campaign. Outpatients with HTN over the age of 18 voluntarily participated in the campaign. During the screening, BP and pulse were measured three times using an automatic or mechanical BP monitor. In addition, a questionnaire was filled out on behavioral risk factors, BP self-monitoring skills, medication adherence, AHT, comorbidities and related therapy. The effectiveness of AHT was understood as achieving the target BP level <140/90 mm Hg in patients with HTN and taking AHT, and BP control — in all hypertensive patients, regardless of taking AHT.Results. The analysis included 7972 respondents aged 18 to 96 years (median age 62 years [51;71]), including 3372 men (42,3%). Among the participants, 74,4% took AHT, while 62,6% achieved target BP <140/90 mm Hg and 25,8% — target BP <130/80 mm Hg. On-demand therapy remains the leading reason for not taking AHT among patients with HTN. Approximately half of the participants (57,7%) answered that they do not use medication reminder systems. Most often, hypertensive patients use BP self-monitoring diaries and pill boxes. Every fifth patient with HTN was registered as taking antihypertensive monotherapy, every third as dual AHT, and every fourth as triple AHT. Single-pill combinations were taken by 34,5% of patients. In outpatient practice, following sex differences were revealed: significantly higher prevalence of taking AHT, using AHT reminder systems, discussions with a doctor, and the effectiveness of treatment and control of HTN were characteristic of female patients. Discussion with a doctor about the importance of following recommendations was associated with a significantly higher achievement of target BP level (odds ratio (OR) 1,43), the use of a single-pill AHT combination (OR 1,3) and statin therapy (OR 1,39), p<0,0001.Conclusion. In outpatient practice after the implementation of 2024 Russian clinical guidelines for HTN, an increase in the coverage and efficacy of AHT, and the HTN control is observed compared to the population data of 2020-2022. AHT prescription profile indicates a decrease in the share of monotherapy and an increase in the share of triple combination. The use of single-pill antihypertensive combinations is growing, but remains insufficient. The results obtained demonstrate the importance of discussing with a physician the need to comply with recommendations in hypertensive patients to improve adherence and treatment effectiveness.

1 January 2017 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
NSNatalya Shimokhina
Natalya Shimokhina
MPM. M. Petrova
M. M. Petrova
ASArray A. Savchenko
Array A. Savchenko
MCM. S. Chernyaeva
M. S. Chernyaeva
According to the World Health Organization, anxiety and depressive disorders will be the second leading cause of disability by 2020. The review is devoted to the modern concepts of the pathophysiology of depression in patients with ischemic heart disease (IHD) and to the possibilities of antidepressant therapy. The paper presents analysis of international and domestic researches devoted to efficiency and safety of agomelatine in patients both with chronic IHD and with unstable angina and acute myocardial infarction. The review also discusses different points of view, indicating the need for further studies to evaluate the short and long term effects of antidepressants in patients with IHD in combination with anxiety and depressive disorders.

6 June 2023 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
NSNatalya Shimokhina
Natalya Shimokhina
ZBZh. R. Baranovich
Zh. R. Baranovich
AYA. S. Yunevich
A. S. Yunevich
ASAndrei Savchenko
Andrei Savchenko
OZO. V. Zimnitskaya
O. V. Zimnitskaya
MPMarina Petrova
Marina Petrova
Objective: to study of the features of the spread of anxiety syndrome in patients with chronic non-communicable diseases (CNCD) in outpatient practice. Materials and methods: the study included persons of both sexes over 18 years of age who visited outpatient facilities in a large industrial center of Eastern Siberia in the summer of 2022. Diagnosis of chronic NCDs was established according to modern clinical guidelines. The examined were divided into two groups. The first group included persons without NCDs, the second group included patients with concomitant NCDs. The psycho-emotional state was assessed using the Spielberger-Khanin test with separate determination of the levels of personal and situational anxiety. Statistical data analysis was carried out using the Statistica 12.0 software package (StatSoft Inc., USA). Results: the level of situational anxiety in patients with chronic NCDs was statistically significantly higher compared to individuals without concomitant somatic pathology. In patients with chronic NCD, compared with individuals without them, a significant increase in the median scores for the level of low and moderately expressed personal anxiety and for the level of moderate and high situational anxiety was revealed. In the group of patients with CND, a high level of personal and situational anxiety was significantly more often observed in comparison with persons without CND. Conclusion: the prevalence of anxiety syndrome, especially situational anxiety in patients with chronic NCD in the outpatient network is quite high and reaches 93%, which requires a solution to the issue of practical psychiatric care for these patients.

16 June 2010 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
NSNatalya Shimokhina
Natalya Shimokhina
MPMarina Petrova
Marina Petrova
ASAndrei Savchenko
Andrei Savchenko
ESE. G. Smertina
E. G. Smertina
VIV. G. Ionova
V. G. Ionova
MTMarine Tanashyan
Marine Tanashyan